Key cause of chronic leukemia progression identified
March 5th, 2010 - 4:25 pm ICT by ANIWashington, March 5 (ANI): Scientists in US have discovered why a form of leukemia progresses from its more-treatable chronic phase to a life-threatening phase called blast crisis.
They found that chronic myeloid leukemia (CML) progresses when immature white blood cells lose a molecule called miR-328.
Loss of the molecule traps the cells in a rapidly growing, immature state. The cells soon fill the bone marrow and spill into the bloodstream, a tell-tale sign that the disease has advanced to the blast crisis stage.
According to the researchers, the study should provide a better understanding of the blast-crisis stage of CML, and it suggests a possible new treatment strategy for the disease.
“These findings indicate that the loss of miR-328 is probably essential for progression from the chronic phase of the disease to the blast crisis stage,” said principal investigator Danilo Perrotti, associate professor of molecular virology, immunology and medical genetics and a member of the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).
“Our findings also suggest that maintaining the level of this microRNA might represent a new therapeutic strategy for CML blast crisis patients who do not benefit from targeted agents such as imatinib (Gleevec) and dasatinib (Sprycel),” Perrotti added.
The study has been published in the March 5th issue of the journal Cell. (ANI)
- Researchers find role of mini-molecules in leukaemia progression - Dec 10, 2007
- Vicious circle' may offer novel acute leukemia treatment target - Apr 14, 2010
- Inflammation may provide breeding ground for cancer - Apr 20, 2011
- Gene mutations help leukemia drug fight squamous cell lung cancer - Apr 04, 2011
- Function of novel molecule that underlies human deafness revealed - Jan 22, 2011
- How dietary supplement could block cancer cells - Jun 30, 2010
- Lung cancer culprit could offer therapeutic target - Sep 14, 2010
- Now, a one-two drug punch approach to KO a lethal cancer - Jun 08, 2009
- Novel approach for leukaemia treatment discovered - Mar 04, 2010
- Second line leukemia drugs hold promise as frontline therapy - Dec 10, 2007
- Scientists make breakthrough in small-cell lung cancer - Jan 14, 2010
- New molecule may save brain cells from neurodegeneration, stroke - Jan 19, 2011
- Scientists convert skin cells to stem cells more effieciently - Feb 03, 2011
- Small molecule may deactivate enemy of cancer-fighting p53 - Dec 08, 2010
- Green tea may help treat chronic leukemia - Jun 05, 2010
Tags: blast crisis, chronic leukemia, chronic myeloid leukemia, chronic phase, comprehensive cancer center, crisis stage, dasatinib, gleevec, imatinib, immature state, james cancer hospital, medical genetics, microrna, molecular virology, ohio state university, perrotti, solove, sprycel, therapeutic strategy, white blood cells
